“Relief. Excitement. Hope. A fantastic day for all of us.’’
That’s how Dr. Colleen Kelley of Emory University School of Medicine described her reaction to preliminary results announced Monday by the biotech company Moderna about its COVID-19 candidate vaccine.
The Massachusetts-based company said its clinical trial has shown the vaccine to be apparently 94.5 percent effective against the virus.
Read this story now for free
To continue reading, sign up for our newsletter and get unlimited access to WABE.org
You can select your preferences for news and local content. We will never share your email address. Learn how your newsletter sign-up will support WABE and Public Media
